» Authors » Farhan Ullah Khan

Farhan Ullah Khan

Explore the profile of Farhan Ullah Khan including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 24
Citations 543
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Ullah Khan F, Khongorzul P, Gris D, Amrani A
Int Immunopharmacol . 2024 Apr; 133:112166. PMID: 38678673
Dendritic cells (DCs) are specialized antigen-presenting cells that play an important role in inducing and maintaining immune tolerance. The altered distribution and/or function of DCs contributes to defective tolerance in...
2.
Guindi C, Ullah Khan F, Cloutier A, Khongorzul P, Raki A, Gaudreau S, et al.
Transl Res . 2022 Nov; 255:37-49. PMID: 36400308
Dendritic cells (DCs) are key regulators of the adaptive immune response. Tolerogenic dendritic cells play a crucial role in inducing and maintaining immune tolerance in autoimmune diseases such as type...
3.
Ullah Khan F, Khongorzul P, Raki A, Rajasekaran A, Gris D, Amrani A
Int J Mol Sci . 2022 May; 23(9). PMID: 35563276
Type 1 diabetes (T1D) results from the destruction of pancreatic beta cells through a process that is primarily mediated by T cells. Emerging evidence suggests that dendritic cells (DCs) play...
4.
Zerif E, Ullah Khan F, Raki A, Lullier V, Gris D, Dupuis G, et al.
Int J Mol Sci . 2020 Sep; 21(18). PMID: 32899608
Tolerogenic dendritic cells (toDCs) are crucial to controlling the development of autoreactive T cell responses and the prevention of autoimmunity. We have reported that NOD.CD11c transgenic mice expressing a constitutively...
5.
Ullah R, Wazir J, Hossain M, Diallo M, Ullah Khan F, Ihsan A, et al.
Wien Klin Wochenschr . 2020 Jun; 133(3-4):153-162. PMID: 32533441
Benign prostatic hyperplasia (BPH) is a common disease that can cause uncomfortable lower urinary tract symptoms. The occurrence of symptomatic BPH develops after the age of 40 years and increases...
6.
Ullah R, Wazir J, Ullah Khan F, Diallo M, Ihsan A, Mikrani R, et al.
AAPS PharmSciTech . 2020 May; 21(4):132. PMID: 32409932
The superiority of nanomedicine over conventional medicines in the treatment of cancer has gained immediate recognition worldwide. As traditional cancer therapies are nonspecific and detrimental to healthy cells, the ability...
7.
Ahsan M, Ullah Khan F, Zhao M, Wang Y
Eur J Pharm Sci . 2020 Apr; 149:105322. PMID: 32289662
Opioid analgesics and the α-adrenergic receptor (αAR) agonists are found to produce synergistic antinociception when administered in combination. In this study interactions between butorphanol and dexmedetomidine were investigated in the...
8.
Khongorzul P, Ling C, Ullah Khan F, Ihsan A, Zhang J
Mol Cancer Res . 2019 Oct; 18(1):3-19. PMID: 31659006
Antibody-drug conjugates (ADC) are one of the fastest growing anticancer drugs. This approach comprises a mAb conjugated to the cytotoxic payload via a chemical linker that directed toward a target...
9.
Wazir J, Ullah R, Li S, Hossain M, Diallo M, Ullah Khan F, et al.
Int Urol Nephrol . 2019 Aug; 51(12):2093-2106. PMID: 31468287
Among one of the four category prostatitis, chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is the disease with unknown etiology and having 90-95% prevalence in prostatitis. CP/CPPS poses adverse psychological effects...
10.
Tang M, Ullah R, Wazir J, Ullah Khan F, Ihsan A, Cui X, et al.
Inflammation . 2019 Aug; 42(6):2086-2094. PMID: 31429013
The exact etiology and pathogenesis of chronic prostatitis (CP/CPPS) remain unclear. However, autoimmunity is a widely known theory. Precise treatment of CP/CPPS is not available. Here, we developed a new...